BASELINE METABOLIC TUMOR VOLUME IS AN INDEPENDENT...

Hematological Oncology 2017 / 06 Vol. 35

BASELINE METABOLIC TUMOR VOLUME IS AN INDEPENDENT PROGNOSTIC FACTOR FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS RECEIVING PET-ADAPTED SALVAGE THERAPY WITH BRENTUXIMAB VEDOTIN AND AUGMENTED ICE

Moskowitz, A.J., Schöder, H., Gavane, S., Thoren, K.L., Fleisher, M., Yahalom, J., McCall, S.J., Fox, S.Y., Gerecitano, J., Grewal, R., Hamlin, P.A., Horwitz, S., Kumar, A., Matasar, M., Ni, A., Noy,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2437_17
Date:
June, 2017
File:
PDF, 162 KB
english, 2017
Conversion to is in progress
Conversion to is failed